Syndax Pharmaceuticals
SNDX
SNDX
196 hedge funds and large institutions have $1.79B invested in Syndax Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 87 increasing their positions, 59 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
4% more funds holding
Funds holding: 189 → 196 (+7)
3.48% less ownership
Funds ownership: 106.26% → 102.79% (-3.5%)
17% less capital invested
Capital invested by funds: $2.15B → $1.79B (-$355M)
Holders
196
Holding in Top 10
11
Calls
$6.62M
Puts
$2.46M
Top Buyers
| 1 | +$18.9M | |
| 2 | +$14.7M | |
| 3 | +$13.1M | |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
+$11.3M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$11.2M |
Top Sellers
| 1 | -$44.7M | |
| 2 | -$44.6M | |
| 3 | -$24.6M | |
| 4 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
-$23.2M |
| 5 |
Morgan Stanley
New York
|
-$21.8M |